- Home
- RLMD vs MKTW Comparison
RLMD vs MKTW Comparison
Compare RLMD & MKTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLMD
- MKTW
- Stock Information
- Founded
- RLMD 2004
- MKTW 1999
- Country
- RLMD United States
- MKTW United States
- Employees
- RLMD N/A
- MKTW N/A
- Industry
- RLMD Biotechnology: Pharmaceutical Preparations
- MKTW Computer Software: Prepackaged Software
- Sector
- RLMD Health Care
- MKTW Technology
- Exchange
- RLMD Nasdaq
- MKTW Nasdaq
- Market Cap
- RLMD 53.4M
- MKTW 48.2M
- IPO Year
- RLMD N/A
- MKTW N/A
- Fundamental
- Price
- RLMD $1.59
- MKTW $17.85
- Analyst Decision
- RLMD Buy
- MKTW Hold
- Analyst Count
- RLMD 3
- MKTW 1
- Target Price
- RLMD $5.00
- MKTW $20.00
- AVG Volume (30 Days)
- RLMD 1.6M
- MKTW 11.8K
- Earning Date
- RLMD 11-06-2025
- MKTW 11-06-2025
- Dividend Yield
- RLMD N/A
- MKTW 4.50%
- EPS Growth
- RLMD N/A
- MKTW 59.71
- EPS
- RLMD N/A
- MKTW 2.83
- Revenue
- RLMD N/A
- MKTW $358,121,000.00
- Revenue This Year
- RLMD N/A
- MKTW N/A
- Revenue Next Year
- RLMD N/A
- MKTW N/A
- P/E Ratio
- RLMD N/A
- MKTW $6.27
- Revenue Growth
- RLMD N/A
- MKTW N/A
- 52 Week Low
- RLMD $0.24
- MKTW $9.08
- 52 Week High
- RLMD $3.98
- MKTW $21.74
- Technical
- Relative Strength Index (RSI)
- RLMD 74.57
- MKTW 46.50
- Support Level
- RLMD $1.44
- MKTW $17.70
- Resistance Level
- RLMD $1.72
- MKTW $18.30
- Average True Range (ATR)
- RLMD 0.24
- MKTW 0.45
- MACD
- RLMD 0.05
- MKTW 0.02
- Stochastic Oscillator
- RLMD 86.90
- MKTW 43.69
About RLMD Relmada Therapeutics Inc.
Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its key product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.
About MKTW MarketWise Inc.
Marketwise Inc is a multi-brand subscription services platform providing premium financial research, software, education, and tools for investors. Its products are built for high-value financial research, education, actionable investment ideas, and investment software. It is a digital, direct-to-consumer company offering its research across a variety of platforms including mobile, desktops, and tablets.